Parus Finance (UK)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,180
| Closed | -$237K | – | 37 |
|
|
2024
Q2 | $237K | Buy |
12,180
+750
| +7% | +$14.6K | 0.07% | 34 |
|
|
2024
Q1 | $429K | Sell |
11,430
-610
| -5% | -$22.9K | 0.16% | 30 |
|
|
2023
Q4 | $674K | Sell |
12,040
-615
| -5% | -$34.4K | 0.35% | 23 |
|
|
2023
Q3 | $522K | Sell |
12,655
-1,315
| -9% | -$54.2K | 0.33% | 22 |
|
|
2023
Q2 | $780K | Sell |
13,970
-149
| -1% | -$8.32K | 0.32% | 23 |
|
|
2023
Q1 | $788K | Buy |
14,119
+384
| +3% | +$21.4K | 0.47% | 23 |
|
|
2022
Q4 | $501K | Sell |
13,735
-580
| -4% | -$21.1K | 0.34% | 27 |
|
|
2022
Q3 | $408K | Buy |
14,315
+906
| +7% | +$25.8K | 0.35% | 26 |
|
|
2022
Q2 | $607K | Sell |
13,409
-35
| -0.3% | -$1.58K | 0.36% | 27 |
|
|
2022
Q1 | $1.02M | Buy |
13,444
+6,180
| +85% | +$470K | 0.37% | 27 |
|
|
2021
Q4 | $1.08M | Buy |
+7,264
| New | +$1.08M | 0.35% | 30 |
|